Oragenics (OGEN) Capital Expenditures (2010 - 2022)
Oragenics' (OGEN) quarterly Capital Expenditures came in at $3438.0 in Q4 2022, down 82.6% YoY from $19753.0 in Q4 2021, and down 90.72% on a QoQ basis from $37034.0 in Q3 2022.
Oragenics (OGEN) Capital Expenditures (2010 - 2022) Analysis & Trends
Oragenics (OGEN) has 8 years of Capital Expenditures data on file, last reported at $3438.0 in Q4 2022.
- Quarterly Capital Expenditures fell 82.6% year-over-year to $3438.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $127519.0 (up 29.99% YoY) and the FY2022 annual result came in at $127519.0, up 190.63% from the prior year.
- Capital Expenditures fell to $3438.0 in Q4 2022, from $37034.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $87047.0 in Q1 2022 to a low of $3438.0 in Q4 2022.
- A 4-year average of $37602.8 and a median of $28393.5 in 2021 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2019 — Capital Expenditures plunged 78.51% — and 2022, when it sank 82.6%.
- Tracing OGEN's Capital Expenditures over 4 years: stood at $64485.0 in 2018, then plunged by 78.51% to $13860.0 in 2019, then surged by 42.52% to $19753.0 in 2021, then slumped by 82.6% to $3438.0 in 2022.
- The last three Capital Expenditures figures came in at $3438.0 (Q4 2022), $37034.0 (Q3 2022), and $87047.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3,438.00 |
| Dec 31, 2022 | 3,438.00 |
| Sep 30, 2022 | 37,034.00 |
| Sep 30, 2022 | 37,034.00 |
| Mar 31, 2022 | 87,047.00 |
| Mar 31, 2022 | 87,047.00 |
| Dec 31, 2021 | 19,753.00 |
| Dec 31, 2021 | 19,753.00 |
| Dec 31, 2019 | 13,860.00 |
| Dec 31, 2019 | 13,860.00 |
| Dec 31, 2018 | 64,485.00 |
| Dec 31, 2018 | 64,485.00 |
| Sep 30, 2015 | 8,622.00 |
| Sep 30, 2015 | 8,622.00 |
| Jun 30, 2015 | 21,652.00 |
| Jun 30, 2015 | 21,652.00 |
| Mar 31, 2015 | 72,237.00 |
| Mar 31, 2015 | 72,237.00 |
| Dec 31, 2014 | 90,544.00 |
| Dec 31, 2014 | 90,544.00 |